Mode
Text Size
Log in / Sign up
N/A Completed N=504

Protecta Smart Analysis Register

Patients With an Indication for an ICD Implantation According to the Guidelines
Source: ClinicalTrials.gov NCT01714921 ↗
Enrolled (actual)
504
Serious AEs
—
Results posted
Nov 2018
Primary outcomePrimary: Analysis of Change of Episodes Inappropriately Treated by Shock Therapy Due to Smart Shock™ Technology. — 94.9 % of episodes wo shock due to SmartShock

Summary

ProSA is a prospective, non-randomized, multicenter, observational study investigating the utilization and effectiveness of the Smart Shock™ algorithm in ICD patients treated with a Protecta™, Protecta™ XT or any equivalent following product.

Outcome Measures

OutcomeResultp-value
PRIMARY
Analysis of Change of Episodes Inappropriately Treated by Shock Therapy Due to Smart Shock™ Technology.
94.9 —
SECONDARY
Number of Patients With All Smart Shock Algorithms Are Programmed on
300 —
SECONDARY
Percentage of Patients, Without Shock Delivery Due to Smart Shock Technology
15.3 —
SECONDARY
Analysis of the Number of Patients With Primary Preventive Indication for an ICD That Develop VF Episodes.
15 —
SECONDARY
Number of Patients That Developed AT/AF
117 —
SECONDARY
Analysis of the Proportion of Patients in Which ICD Parameters Remain on Nominal Programming.
421 —
SECONDARY
Analysis of the Positive Predictive Value of the Investigated ICD Oversensing Algorithms
100 —

Eligibility Criteria

Inclusion Criteria

  • patients implanted with an Implantable Cardioverter Defibrillator (ICD) with the smart shock algorithm (Protecta™, Protecta™ XT or any equivalent following product)
  • written informed consent

Exclusion Criteria

  • patients with life expectancy less than 24 months
  • patients younger than 18 years
  • pregnant or breast feeding women
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01714921). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search